106 related articles for article (PubMed ID: 593967)
1. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
Pérez A; Ledea N; Hermández K; Garcia-Barreto D
Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.
Mirro MJ; Manalan AS; Bailey JC; Watanabe AM
Circ Res; 1980 Dec; 47(6):855-65. PubMed ID: 7192183
[TBL] [Abstract][Full Text] [Related]
3. Comments on: "anticholinergic effects of disopyramide and quinidine on guinea pig myocardium--mediation by direct muscarinic receptor blockade".
Benfey BG
Circ Res; 1981 Sep; 49(3):821. PubMed ID: 7261276
[No Abstract] [Full Text] [Related]
4. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
Luo C; Wang K; Zhang H
PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
[TBL] [Abstract][Full Text] [Related]
5. The electrophysiology of Norpace (Part I).
Dreifus LS
Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
[No Abstract] [Full Text] [Related]
6. [Comparison of the effects of disopyramide and hydroquinidine in animals].
Lisin N; Carlier J
Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
[No Abstract] [Full Text] [Related]
7. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
Nattel S; Bailey JC
J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
[TBL] [Abstract][Full Text] [Related]
8. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs.
Hasannejad H; Takeda M; Narikawa S; Huang XL; Enomoto A; Taki K; Niwa T; Jung SH; Onozato ML; Tojo A; Endou H
Eur J Pharmacol; 2004 Sep; 499(1-2):45-51. PubMed ID: 15363950
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
Deng XF; Mulay S; Chemtob S; Varma DR
J Pharmacol Exp Ther; 1997 Apr; 281(1):322-9. PubMed ID: 9103513
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic effect of disopyramide injected into the sinus nodal artery.
Garcia-Barreto D; Pérez-Medina T
Acta Physiol Acad Sci Hung; 1977; 49(3-4):231-5. PubMed ID: 755338
[TBL] [Abstract][Full Text] [Related]
11. [Experimental studies of the hemodynamics of disopyramide in comparison with quinidine].
Hoffmeister HM; Hepp A; Seipel L
Z Kardiol; 1988 Jan; 77(1):48-52. PubMed ID: 3363980
[TBL] [Abstract][Full Text] [Related]
12. Concurrent use of quinidine and disopyramide: evaluation of serum concentrations and electrocardiographic effects.
Baker BJ; Gammill J; Massengill J; Schubert E; Karin A; Doherty JE
Am Heart J; 1983 Jan; 105(1):12-5. PubMed ID: 6849225
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of disopyramide and bethanechol: use of bethanechol to prevent anticholinergic side effects of disopyramide without reduction of antiarrhythmic efficacy.
Konishi T; Kadoya M; Ikeguchi S; Sakai K; Tamamura T; Kawai C
J Cardiovasc Pharmacol; 1989 Aug; 14(2):341-50. PubMed ID: 2476611
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac purkinje fibers. Dependence on underlying cholinergic tone.
Mirro MJ; Watanabe AM; Bailey JC
Circ Res; 1980 May; 46(5):660-8. PubMed ID: 7363415
[No Abstract] [Full Text] [Related]
15. [Comparison of the effects of quinidine, diphenylhydantoin and disopyramide on the auricular refractory period in the anesthetized dog].
Duchêne-Marullaz P; Lapalus P; Lavarenne J; Combre A
Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):150-8. PubMed ID: 4460907
[No Abstract] [Full Text] [Related]
16. Disopyramide in patients with ventricular premature beats: an experimental model and preliminary results.
Hohansson BW; Persson S
J Int Med Res; 1976; 4(1 Suppl):96-9. PubMed ID: 1026538
[No Abstract] [Full Text] [Related]
17. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
Mathur PP
Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
[No Abstract] [Full Text] [Related]
19. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
Stauch M; Grewe N; Nissen H
MMW Munch Med Wochenschr; 1976 Mar; 118(11):331-4. PubMed ID: 57570
[TBL] [Abstract][Full Text] [Related]
20. Disopyramide phosphate: is it just another quinidine.
Kus T; Sasyniuk BI
Can J Physiol Pharmacol; 1978 Apr; 56(2):326-31. PubMed ID: 638888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
